Point72 Hong Kong’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-286
| Closed | -$69.7K | – | 465 |
|
|
2025
Q1 | $69.7K | Buy |
+286
| New | +$69.7K | ﹤0.01% | 347 |
|
|
2024
Q4 | – | Sell |
-165
| Closed | -$55.2K | – | 402 |
|
|
2024
Q3 | $55.2K | Buy |
+165
| New | +$55.2K | ﹤0.01% | 361 |
|
|
2024
Q1 | – | Sell |
-22,517
| Closed | -$7.27M | – | 545 |
|
|
2023
Q4 | $7.27M | Buy |
+22,517
| New | +$7.27M | 0.44% | 64 |
|
|
2022
Q4 | – | Sell |
-5,800
| Closed | -$2.42M | – | 196 |
|
|
2022
Q3 | $2.42M | Buy |
5,800
+1,715
| +42% | +$715K | 0.08% | 191 |
|
|
2022
Q2 | $2.02M | Buy |
+4,085
| New | +$2.02M | 0.07% | 207 |
|
|
2022
Q1 | – | Sell |
-1,493
| Closed | -$1.13M | – | 1360 |
|
|
2021
Q4 | $1.13M | Sell |
1,493
-352
| -19% | -$266K | 0.04% | 180 |
|
|
2021
Q3 | $1.38M | Buy |
+1,845
| New | +$1.38M | 0.04% | 218 |
|
|
2021
Q2 | – | Sell |
-3,370
| Closed | -$1.93M | – | 1374 |
|
|
2021
Q1 | $1.93M | Buy |
+3,370
| New | +$1.93M | 0.06% | 162 |
|
|
2020
Q3 | – | Sell |
-1,334
| Closed | -$602K | – | 1200 |
|
|
2020
Q2 | $602K | Buy |
1,334
+1,205
| +934% | +$544K | 0.07% | 298 |
|
|
2020
Q1 | $45K | Sell |
129
-980
| -88% | -$342K | 0.02% | 369 |
|
|
2019
Q4 | $410K | Buy |
1,109
+311
| +39% | +$115K | 0.1% | 168 |
|
|
2019
Q3 | $266K | Buy |
798
+738
| +1,230% | +$246K | 0.08% | 226 |
|
|
2019
Q2 | $19K | Buy |
+60
| New | +$19K | 0.01% | 784 |
|
|
2018
Q2 | – | Sell |
-118
| Closed | -$30K | – | 899 |
|
|
2018
Q1 | $30K | Buy |
+118
| New | +$30K | 0.02% | 559 |
|
|
2017
Q4 | – | Sell |
-194
| Closed | -$43K | – | 851 |
|
|
2017
Q3 | $43K | Buy |
+194
| New | +$43K | 0.03% | 275 |
|
|
2017
Q1 | – | Sell |
-874
| Closed | -$159K | – | 743 |
|
|
2016
Q4 | $159K | Buy |
+874
| New | +$159K | 0.16% | 166 |
|
|
2015
Q4 | – | Sell |
-500
| Closed | -$67K | – | 495 |
|
|
2015
Q3 | $67K | Buy |
500
+100
| +25% | +$13.4K | 0.1% | 69 |
|
|
2015
Q2 | $60K | Buy |
+400
| New | +$60K | 0.12% | 112 |
|